Mark McClanahan
Family Medicine · Floydada, TXNPI 1750377198
Payments from drug & device makers
Across 237 payments — averaging $13.26 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- GSK$825
- AstraZeneca$733
- Merck$221
- Novo Nordisk$208
- Pacira Pharmaceuticals Incorporated$200
- AbbVie$163
- plus $795 from 23 others
What the payments were for
- Food & beverage$3,143100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| GSK | 103 | $825 |
| AstraZeneca | 45 | $733 |
| Merck | 16 | $221 |
| Novo Nordisk | 14 | $208 |
| Pacira Pharmaceuticals Incorporated | 2 | $200 |
| AbbVie(2 entities) | 11 | $163 |
| Harmony Biosciences LLC | 1 | $103 |
| Pfizer | 7 | $96 |
| Sanofi-aventis U.S. LLC | 5 | $77 |
| Amarin Pharma, Inc. | 4 | $63 |
| Nestle Healthcare Nutrition Inc. | 3 | $51 |
| Lilly USA, LLC | 4 | $50 |
| Inspire Medical Systems, Inc. | 1 | $41 |
| Daiichi Sankyo Inc. | 2 | $40 |
| Abbott | 2 | $34 |
| Amgen | 2 | $25 |
| Boehringer Ingelheim | 2 | $24 |
| Otsuka America Pharmaceutical, Inc. | 1 | $24 |
| Axsome Therapeutics, Inc. | 1 | $23 |
| Bayer | 1 | $19 |
| Sanofi Pasteur Inc. | 1 | $17 |
| Astellas Pharma US Inc | 1 | $16 |
| Organon | 2 | $15 |
| Scynexis, Inc. | 1 | $14 |
| Exact Sciences | 1 | $14 |
| Mylan Specialty L.p. | 1 | $14 |
| Radius Health, Inc. | 1 | $12 |
| Supernus Pharmaceuticals, Inc. | 1 | $11 |
| Kowa Pharmaceuticals America, Inc. | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$3,143 in reported general payments places this provider in the 80th percentile of 8,760 family medicine providers in Texas.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MounjaroTirzepatide | 14 | $15,831 |
| EliquisApixaban | 16 | $14,487 |
| Breo ElliptaFluticasone/Vilanterol | 12 | $5,040 |
| Gabapentin | 60 | $1,553 |
| Omeprazole | 75 | $836 |
| Levothyroxine Sodium | 89 | $751 |
| Losartan Potassium | 52 | $708 |
| Atorvastatin Calcium | 81 | $621 |
| ClopidogrelClopidogrel Bisulfate | 35 | $571 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 21 | $546 |
| Pantoprazole Sodium | 43 | $496 |
| Rosuvastatin Calcium | 34 | $446 |
| Lisinopril | 64 | $441 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 15 | $427 |
| Fluticasone Propionate | 23 | $371 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Lilly USA, LLCMounjaro | $50 | $15,83114 claims |
| PfizerEliquis | $96 | $14,48716 claims |
| GSKBreo Ellipta | $825 | $5,04012 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 8,760 family medicine providers in Texas.
Other family medicine in Floydada
- Douglas DenhamSan Antonio$68.5M
- Vicki MillerPasadena$58.3M
- Hareshkumar BogharaDesoto$30.3M
- Earl MartinTomball$30.1M
- Lisa HollowayHouston$30.1M
- William SegerFort Worth$27.5M
- Veronica FragosoHouston$24.5M
- Joel SolisMcAllen$21.1M
- George AtieeSan Antonio$19.9M
- Bonnie ColvilleHouston$19.6M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.